CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction-Reference-Cited by-同舟云学术

CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction

Published:2023-01 Issue:1 Volume:23 Page:37-44
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Calabrese Daniel R.^ORCID,Chong Tiffany,Singer Jonathan P.^ORCID,Rajalingam Raja^ORCID,Hays Steven R.,Kukreja Jasleen,Leard Lorriana,Golden Jeffrey A.,Lanier Lewis L.,Greenland John R.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference53 articles.

1. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome;Meyer;Eur Respir J,2014

2. De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome;Le Pavec;J Heart Lung Transplant,2016

3. Human leukocyte antigens antibodies after lung transplantation: primary results of the HALT study;Hachem;Am J Transplant,2018

4. Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation;Angaswamy;Hum Immunol,2010

5. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation;Hachem;J Heart Lung Transplant,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms;Transplantation;2024-08-06

2. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression;The Journal of Heart and Lung Transplantation;2024-07

3. Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword;Frontiers in Transplantation;2024-06-10

4. The diagnosis and management of chronic lung allograft dysfunction;Current Opinion in Pulmonary Medicine;2024-02-02

5. Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies;American Journal of Transplantation;2023-12